Anticancer Activity of Propolis Extract-ZnO Nanocomposite Against Human Lung Carcinoma Cell Line | ||||
| Egyptian Journal of Chemistry | ||||
| Volume 67, Issue 5, May 2024, Page 165-174 PDF (1.02 MB) | ||||
| Document Type: Original Article | ||||
| DOI: 10.21608/ejchem.2023.230583.8461 | ||||
 View on SCiNiTO | ||||
| Authors | ||||
Naglaa M. Ismail  1; Soheir Korraa2; Amany T. Sroor1; Amira Abdel Rehim Qotb1
| ||||
| 1Physics department- Faculty of Women for Arts, Science and Education- Ain Shams University, Egypt | ||||
| 2Radiation Health Department- National Center for Radiation Research and Technology – Atomic Energy Authority, Egypt | ||||
| Abstract | ||||
| This study aimed to evaluate the synergistic effect of propolis extract-zinc oxide (EEP-ZnO) nanocomposite against human lung carcinoma cell line. EEP-ZnO nanocomposite was formulated by the combination of Zinc Oxide nanoparticles (ZnO NPs) with ethanolic propolis extract (EEP) that was characterized by X-ray diffraction (XRD), Transmission electron microscopy (TEM) and Fourier transform infrared spectroscopy (FT-IR). The MTT assay and Annexin V-PI apoptosis assay were used for cytotoxicity evaluation of prepared EEP-ZnO nanocomposite against human lung carcinoma cell line (A549) and human lung normal cell line (WI-38). Results showed that the propolis extract- zinc oxide nanocomposite significantly decreased cell viability and increased cell apoptosis, as compared to EEP and ZnO NPs alone. It was also observed that EEP, ZnO NPs, and EEP-ZnO nanocomposite are exhibited a less toxic effect on WI-38 comparable to A549. | ||||
| Keywords | ||||
| Propolis extract; Zinc oxide nanoparticle; MTT assay; Apopotosis | ||||
|
Statistics Article View: 685 PDF Download: 264 |
||||
